Condition: Schizophenia Disorder · Schizoaffective Disorder · Bipolar Disorder I or II · Sponsor: New York State Psychiatric Institute
This is a single site trial in 30 patients with schizophrenia, schizoaffective, or bipolar I/II/NOS disorder in which all participants will receive eight weeks of olanzapine and samidorphan (Olz/Sam) plus four weeks of aerobic exercise.
This description comes directly from the study's public registry record.
Megan Mayer, BA · 646-774-8477 · megan.mayer@nyspi.columbia.edu
Joshua T Kantrowitz, MD · 646-774-6738 · joshua.kantrowitz@nyspi.columbia.edu
Always discuss trial participation with your own doctor first.
| New York State Psychiatric Institute | New York, New York, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06740890